Models of neuroinflammation for the assessment of kappa-opioid receptor ligands
The development of new drugs to combat neuroinflammation is highly relevant as it opens up possibilities for the treatment of a wide range of diseases, including Alzheimer's disease, Parkinson's disease, epilepsy, schizophrenia, depression, and others. Kappa-opioid agonists represent a pro...
Saved in:
Main Authors: | K. Yu. Kalitin (Author), A. A. Spasov (Author), O. Yu. Mukha (Author) |
---|---|
Format: | Book |
Published: |
Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Electrophysiological effects of kappa-opioid analgesic, RU-1205, using machine learning methods
by: K. Yu. Kalitin, et al.
Published: (2024) -
Effects of kappa-opioid agonist U-50488 and p38 MAPK inhibitor SB203580 on the spike activity of pyramidal neurons in the basolateral amygdala
by: Konstantin Y. Kalitin, et al.
Published: (2024) -
Aversion-related effects of kappa-opioid agonist U-50488 on neural activity and functional connectivity between amygdala, ventral tegmental area, prefrontal cortex, hippocampus, and nucleus accumbens
by: Konstantin Y. Kalitin, et al.
Published: (2023) -
Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands
by: Chiara Sturaro, et al.
Published: (2022) -
Itching-like behavior: A common effect of the kappa opioid receptor antagonist 5'-guanidinonaltrindole and the biased kappa opioid receptor agonist 6'-guanidinonaltrindole in mice
by: Alan Cowan, et al.
Published: (2021)